TABLE 3.
Bacterial isolates at enrollment and after 3 weeks of treatment
| Microorganisma | No. (%) of isolates
|
|||
|---|---|---|---|---|
| Enrollment
|
Wk 3
|
|||
| G-CSF group (n = 20) | Control group (n = 20) | G-CSF group (n = 20) | Control group (n = 20) | |
| Gram-positive aerobes | ||||
| CNS-MS | 1 | 5 | ||
| CNS-MR | 5 | 3 | ||
| SA-MS | 8 | 8 | 1 | |
| SA-MR | 2 | 2 | 2 | 1 |
| Corynebacterium spp. | 2 | 2 | 2 | 1 |
| Enterococcus spp. | 7 | 3 | ||
| Streptococcus agalactiae | 4 | 4 | ||
| Streptococcus pyogenes | 2 | |||
| Gram-negative aerobes | ||||
| Pseudomonas aeruginosa | 1 | 1 | ||
| Escherichia coli | 4 | 1 | 2 | |
| Proteus mirabilis | 2 | |||
| Enterobacter aerogenes | 1 | |||
| Klebsiella pneumoniae | 1 | |||
| Anaerobes | ||||
| Bacteroides fragilis | 5 | 2 | ||
| Fusobacterium spp. | 2 | 1 | ||
| Peptostreptococcus spp. | 4 | 1 | ||
| Prevotella bivia | 1 | |||
| Total | 41 (55) | 33 (45) | 11 (58) | 8 (42) |
a
CNS-MS, methicillin-sensitive, coagulase negative staphylococci; CNS-MR, methicillin resistant, coagulase negative staphylococci; SA-MS, methicillin sensitive Staphylococcus aureus; SA-MR, methicillin resistant Staphylococcus aureus.